Edition:
United Kingdom

People: Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,950.00GBp
12:27pm BST
Change (% chg)

46.00 (+1.58%)
Prev Close
2,904.00
Open
2,906.00
Day's High
2,962.00
Day's Low
2,906.00
Volume
34,506
Avg. Vol
171,560
52-wk High
3,163.00
52-wk Low
1,992.00

Page, Ian 

Mr. Ian David Page is a Chief Executive Officer, Executive Director of Dechra Pharmaceuticals PLC. Ian has gained detailed knowledge and experience through various positions he has held within the pharmaceutical and veterinary arena. He has a solid understanding of business development both in the UK and globally. In particular he has extensive experience in M&A and in the successful delivery of strategic plans. Ian joined NVS, Dechra’s former services business, at its formation in 1989 and was an integral part of the management buyout in 1997, becoming its Managing Director in 1998. He joined the Board in 1997 and became Chief Executive Officer in 2001. Ian has played a key role in the development of the Group’s growth strategy.

Basic Compensation

Total Annual Compensation, GBP 945,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP 2,514,000
All Other, GBP 77,000
Fiscal Year Total, GBP 3,536,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Rice

126,000

Ian Page

3,536,000

Paul Sandland

--

Mike Eldred

--

Anthony Griffin

1,195,000

Katy Clough

--
As Of  30 Jun 2018